Patent Waiver on Covid-19 Vaccines Splits Opinions in Biotech Industry
Attempts to increase global Covid-19 vaccine coverage with a temporary patent waiver have been met…
15/06/2021 - 5 minutes
RNA technology
The Coming of Age Story of RNAi Technology
The first RNA interference therapy was approved in 2018, after 20 years in development. What…
02/06/2021 - 6 minutes
How Are European Biotechs Tackling the Cardiovascular Disease Problem?
Cardiovascular diseases may not regularly grab the headlines, but they’re the leading cause of mortality…
01/03/2021 - 9 minutes
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
28/12/2020 - 12 minutes
Overcoming the Limitations of CRISPR Gene Editing with RNA Editing
A once forgotten technology, RNA editing has been gaining traction as a treatment for genetic…
17/08/2020 - 6 minutes
Silence Therapeutics to Work with AstraZeneca in RNAi Deal Worth up to €3.6B
AstraZeneca is recruiting RNAi specialist Silence Therapeutics to develop treatments for cardiovascular, renal, metabolic, and…
26/03/2020 - 3 minutes
Alnylam Gets Second RNAi Drug Approval from EMA
US biotech Alnylam Pharmaceuticals has succeeded in getting its second RNAi drug -- for treatment…
03/03/2020 - 2 minutes
CureVac Bids to Develop First mRNA Coronavirus Vaccine
RNA vaccine developer CureVac will receive a grant of up to €8.3M from a global…
03/02/2020 - 2 minutes
AstraZeneca Recruits RNA Biotech to Develop Metabolic Disease Therapies
The UK biotech MiNA Therapeutics has launched a collaboration with AstraZeneca to develop small activating…
07/01/2020 - 2 minutes
BioNTech’s RNA-Boosted CAR T-Cell Therapy Shrinks Tumors in Mice
A CAR T-cell therapy amplified by RNA technology, developed by BioNTech, has shown preclinical potential…
06/01/2020 - 2 minutes
European Biotech’s Top News in 2019
With the year coming to a close, it’s time to review the most important biotech…
30/12/2019 - 10 minutes
Novartis Enters RNA Therapeutics with Medicines Company Merger
Novartis is to acquire The Medicines Company and its late-stage RNA interference drug designed to…
25/11/2019 - 3 minutes
